The factors for predicting hospital mortality in early stage of severe acute pancreatitis.

Author(s):  
Masayasu Horibe
2020 ◽  
Vol 21 (4) ◽  
pp. 131-134
Author(s):  
O. G. Sivkov ◽  
◽  
A. O. Sivkov ◽  

Aim. To study urinary nitrogen excretion at the early stage of severe acute pancreatitis. Materials and methods. Prospective, single-center, cohort study. Inclusion criteria: diagnosis of acute pancreatitis and presence of at least one of the predictors of severe course. Among all patients (n = 72), a cohort of patients with severe acute pancreatitis (n = 32) was allocated. Three groups were formed in it: the first one – all patients, the second one – survivors (n = 24), the third one – deceased (n = 8). Urinary nitrogen excretion was determined using the Deacon formula. Measurements were performed on the first, third and fifth days of the disease. Statistical processing of the material was carried out by the SPSS software package. The null hypothesis was rejected at p < 0.05. Results. In the first week of the disease in all groups, the maximum urinary nitrogen excretion occurs on the 3rd day. When comparing the results of the second and third groups, it was found that the urinary nitrogen excretion on the first and fifth days did not have a statistically significant difference between the groups (respectively, p = 0.138, p = 0.572), and the results of the third day have (p = 0.014). A similar pattern remains when recalculating the nitrogen loss in the urine to the ideal weight; for the third day, the differences between the second and third groups were statistically significant (p = 0.007). ROC analysis of urinary nitrogen excretion of the third day calculated to the ideal body weight showed an area under the curve of 0.813 (p < 0.009). The value at the cut-off point is defined as 0.65 g/kg/day. The sensitivity of the model was 0.75%, specificity – 0.83%. Conclusion. If in a patient with acute pancreatitis, there is urinary nitrogen excretion on the third day from the onset of the disease, calculated to an ideal body weight of ≥ 0.65 g/kg/day, an unfavorable outcome of the disease is predicted.


2013 ◽  
Vol 144 (5) ◽  
pp. S-276 ◽  
Author(s):  
Yoshihisa Tsuji ◽  
Tsubasa Watanabe ◽  
Hiroshi Yamamoto ◽  
Tsutomu Chiba

Pancreatology ◽  
2015 ◽  
Vol 15 (5) ◽  
pp. 497-502 ◽  
Author(s):  
Yun Sun ◽  
Zhong-hua Lu ◽  
Xin-shu Zhang ◽  
Xiao-ping Geng ◽  
Li-jun Cao ◽  
...  

Pancreatology ◽  
2009 ◽  
Vol 9 (6) ◽  
pp. 770-776 ◽  
Author(s):  
Timothy B. Gardner ◽  
Santhi Swaroop Vege ◽  
Suresh T. Chari ◽  
Bret T. Petersen ◽  
Mark D. Topazian ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Tongtian Ni ◽  
Ying Chen ◽  
Bing Zhao ◽  
Li Ma ◽  
Yi Yao ◽  
...  

AbstractSevere acute pancreatitis (SAP) is a life-threatening disease. Fluid Resuscitation Via Colon (FRVC) may be a complementary therapy for early controlled fluid resuscitation. But its clinical application has not been reported. This study aims to explore the impact of FRVC on SAP. All SAP patients with the first onset within 72 h admitted to the hospital were included from January 2014 to December 2018 through electronic databases of Ruijin hospital and were divided into FRVC group (n = 103) and non-FRVC group (n = 78). The clinical differences before and after the therapy between the two groups were analyzed. Of the 181 patients included in the analysis, the FRVC group received more fluid volume and reached the endpoint of blood volume expansion ahead of the non-FRVC group. After the early fluid resuscitation, the inflammation indicators in the FRVC group were lower. The rate of mechanical ventilation and the incidence of hypernatremia also decreased significantly. Using pure water for FRVC was more helpful to reduce hypernatremia. However, Kaplan–Meier 90-day survival between the two groups showed no difference. These results suggest that the combination of FRVC might benefit SAP patients in the early stage of fluid resuscitation, but there is no difference between the prognosis of SAP patients and that of conventional fluid resuscitation. Further prospective study is needed to evaluate the effect of FRVC on SAP patients.


Pancreatology ◽  
2016 ◽  
Vol 16 (1) ◽  
pp. S29
Author(s):  
Jing Hu ◽  
Pei-lin Li ◽  
Jing Huo ◽  
Ming-wei Li ◽  
Yang Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document